Evolent Health, Inc Class A Common Stock (EVH) is a publicly traded Healthcare sector company. As of July 23, 2026, EVH trades at $5.30 with a market cap of $658.01M and a P/E ratio of -1.18. EVH moved -4.87% today. Year to date, EVH is +39.25%; over the trailing twelve months it is -42.99%. Its 52-week range spans $2.10 to $13.21. Analyst consensus is buy with an average price target of $5.94. Rallies surfaces EVH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EVH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EVH recently traded at $5.30. Market cap is $658.01M. P/E ratio is -1.18. Revenue is $1.89B.
| Metric | Value |
|---|---|
| Price | $5.30 |
| Market Cap | $658.01M |
| P/E Ratio | -1.18 |
| EPS | $-4.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.21 |
| 52-Week Low | $2.10 |
| Volume | 29.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.89B |
| Net Income | $-533.78M |
| Gross Margin | 20.18% |
11 analysts cover EVH: 0 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.94.